Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Adalimumab Inj 40 Mg/0.4 Ml (CDM 4303286) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 30, 2026 , from http://ppman.hank.ai/transparency/procedure/4303286/by-state?code_type=CDM
“Adalimumab Inj 40 Mg/0.4 Ml (CDM 4303286) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4303286/by-state?code_type=CDM. Accessed
October 30, 2026 .
“Adalimumab Inj 40 Mg/0.4 Ml (CDM 4303286) by State,” HANK Price Transparency ,
accessed October 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/4303286/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
4303286 — Adalimumab Inj 40 Mg/0.4 Ml
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$4,167
National median
$3,954 – $6,124
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4303286 (CDM), with interquartile range
State Median p25 p75
NE $4,167 $3,954 $6,124